Enlicitide Decanoate for hyperlipoproteinemia type ii

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 3 registered trials.

Why this status

  1. 19 Jul 2023: Trial registered, NCT05952856
  2. 19 Jul 2023: Trial registered, NCT05952869
  3. 8 Aug 2023: Trial started, NCT05952869
  4. 10 Aug 2023: Trial started, NCT05952856

The trials

NCT05261126: A Study of the Efficacy and Safety of Enclitide Chloride (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-008)

State
Completed
Phase
Phase 2
People
381 taking part
Started
10 Mar 2022
Primary completion
28 Nov 2022
Arms
Enclitide Chloride 6 mg, Enclitide Chloride 12 mg, Enclitide Chloride 18 mg, Enclitide Chloride 30 mg
Results
Posted on the registry
  1. 2 Mar 2022: Trial registered
  2. 10 Mar 2022: Trial started
  3. 28 Nov 2022: Trial completed
  4. 6 Dec 2023: Trial results posted

NCT05952856: A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids

State
Completed
Phase
Phase 3
People
2,912 taking part
Started
10 Aug 2023
Primary completion
28 Jul 2025
Arms
Enlicitide Decanoate
Results
Posted on the registry
  1. 19 Jul 2023: Trial registered
  2. 10 Aug 2023: Trial started
  3. 28 Jul 2025: Trial completed
  4. 6 Aug 2026: Trial results posted

NCT05952869: A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Heterozygous Familial Hypercholesterolemia (MK-0616-017/CORALreef HeFH)

State
Completed
Phase
Phase 3
People
303 taking part
Started
8 Aug 2023
Primary completion
7 Apr 2025
Arms
Enlicitide Decanoate
Results
Posted on the registry
  1. 19 Jul 2023: Trial registered
  2. 8 Aug 2023: Trial started
  3. 7 Apr 2025: Trial completed
  4. 24 Feb 2026: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Enclitide Chloride, Lipfendra.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.